Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: Partners in viral life and host cell death

Cell Death and Differentiation

Volumn 12, Issue , 2005, Pages 932-941

  Matarrese, P ^a   Malorni, W ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Apoptosis; Cytoskeleton; Hiv 1; Microfilaments; Microtubules

Indexed keywords

ACTIN BINDING PROTEIN; NEF PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VPR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACTIN FILAMENT; APOPTOSIS; CELL DEATH; CELL FATE; CELL INTERACTION; CELL MOTION; CELL POLARITY; CELL SHAPE; CYTOPLASM; CYTOSKELETON; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROFILAMENT; MICROTUBULE; NONHUMAN; PATHOGENESIS; POLARIZATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS ASSEMBLY; VIRUS PARTICLE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 22744453432     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401582     Document Type: Review

References (109)

1. Etienne-Manneville S and Hall A (2002) Rho GTPases in cell biology. Nature 420: 629-635
2. Fiorentini C, Falzano L, Fabbri A, Stringaro A, Logozzi M, Travaglione S, Contamin S, Arancia G, Malorni W and Fais S (2001) Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. Mol. Biol. Cell. 12: 2061-2073
3. Iyengar S, Hildreth JE and Schwartz DH (1998) Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J. Virol. 72: 5251-5255
4. Viard MI, Parolini M, Sargiacomo M, Fecchi K, Ramoni C, Ablan S, Ruscetti FW, Wang JM and Blumenthal R (2002) Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J. Virol. 76: 11584-11595
5. McDonald D, Vodicka A, Lucero G, Svitkina TM, Borisy GG, Emerman M and Hope TJ (2002) Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 159: 441-452
6. Bukrinskaya A, Brichacek B, Mann A and Stevenson M (1998) Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188: 2113-2125
7. del Real G, Jimenez-Baranda S, Mira E, Lacalle RA, Lucas P, Gomez-Mouton C, Alegret M, Pena JM, Rodriguez-Zapata M, Alvarez-Mon M, Martinez AC and Manes S (2004) Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 200: 541-547
8. Campbell EM, Nunez R and Hope TJ (2004) Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 78: 5745-5755
9. Anderson JL and Hope TJ (2003) Recent insights into HIV accessory proteins. Curr. Infect. Dis. Rep. 5: 439-450
10. Simmons A, Aluvihare V and McMichael F (2001) Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14: 763-777
11. Aiken C, Konner J, Landau NR, Lenburg ME and Trono D (1994) Nef induces CD4 endocytosis requirement for a critical dileucine motif in the membraneproximal CD4 cytoplasmic domain. Cell 76: 853-864
12. Aiken C and Trono D (1995) Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69: 5048-5056
13. Miller MD, Warmerdam T, Gaston I, Greene WC and Feinberg MB (1994) The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179: 101-113
14. Schwartz O, Marechal V, Danos O and Heard JM (1995) Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69: 4053-4059
15. Fackler OT, Kienzle N, Kremmer E, Boese A, Scramm B, Klimkait C, Kucherer C and Muller-Lantzsch N (1997) Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur. J. Biochem. 247: 843-851
16. Daniels RH and Bokoch GM (1998) p21-activated kinase: a crucial component of morphological signaling? Trends Biochem. Sci. 247: 350-355
17. Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch MG and Chernoff J (1997) Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7: 338-342
18. Fackler OT, Luo W, Geyer M, Alberts AS and Peterlin BM (1999) Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector function. Mol. Cell 3: 729-939
19. Quaranta MG, Mattioli B, Spadaro F, Straface E, Giordani L, Ramoni C, Malorni W and Viora M (2003) HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 17: 2025-2036
20. Hayward RD and Koronakis V (2002) Direct modulation of the host cell cytoskeleton by Salmonella actin-binding proteins. Trends Cell Biol. 12: 15-20
21. Forshey BM and Aiken C (2003) Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex. J. Virol. 77: 4409-4414
22. Kotov A, Zhou J, Flicker P and Aiken C (1999) Association of Nef with the human immunodeficiency virus type 1 core. J. Virol. 73: 8824-8833
23. Goldsmith MA, Warmerdam MT, Atchinson E, Miller MD and Greene WC (1995) Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69: 4112-4121
24. Rey OJ, Canon J and Krogstad P (1996) HIV-1 Gag protein associates with F-actin present in microfilaments. Virology 220: 530-534
25. Pearce-Pratt RD, Malamud D and Phyllips DM (1994) Role of cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J. Virol. 68: 2898-2905
26. Perotti ME, Tan X and Phillips D (1996) Directional budding of human immunodeficiency virus from monocytes. J. Virol. 70: 5916-5921
27. Cooper JA (1987) Effects of cytochalasin and phalloidin on actin. J. Cell Biol. 105: 1473-1478
28. Sasaki H, Nakamura M, Ohno T, Matsuda Y, Yuda Y and Nonomura Y (1995) Myosyn-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc. Natl. Acad. Sci. USA 92: 2026-2030
29. Ott DE, Coren LV, Kane BP, Busch LK, Johnson DG, Sowder RCN, Chertova EN, Arthur LO and Henderson LE (1996) Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70: 7734-7743
30. Bennett RP, Nelle TD and Wills W (1993) Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 76: 6487-6498
31. Wills JW and Craven RC (1991) From, function, and use of retroviral gag proteins. AIDS 5: 639-654 (Editorial)
32. Ibarrondo FJ, Choi R, Geng YZ, Canon J, Rey O, Baldwin GC and Krogstad P. (2001) HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. AIDS Res. Hum. Retroviruses 17: 1489-1500
33. Cudmore S, Reckmann I and Way M (1997) Viral manipulations of the actin cytoskeleton. Trends Microbiol. 5: 142-148
34. Handley MA, Paddock S, Dall A and Panganiban AT (2001) Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein. Virology 291: 198-207
35. Sodeik B (2000) Mechanisms of viral transport in the cytoplasm. Trends Microbiol. 8: 465-472
36. Smith GA and Enquist LW (2002) Break ins and break outs: viral interactions with the cytoskeleton of Mammalian cells. Annu. Rev. Cell Dev. Biol. 18: 135-161
37. Bukrinskaya A, Brichacek B, Mann A and Stevenson M (1998) Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188: 2113-2125
38. Spector I, Shochet NR, Blasberger D and Kashman Y (1989) Latrunculins - novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. Cell Motil. Cytoskeleton 3: 127-144
39. Sasaki H, Ozaki H, Karaki H and Nonomura Y (2004) Actin filaments play an essential role for transport of nascent HIV-1 proteins in host cells. Biochem. Biophys. Res. Commun. 316: 588-593
40. Johnson DC and Huber MT (2002) Directed egress of animal viruses promotes cell-to-cell spread. J. Virol. 76: 1-8
41. Fais S, Capobianchi MR, Abbate I, Castilletti C, Gentile M, Cordiali Fei P, Ameglio F and Dianzani F (1995) Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein. AIDS 9: 329-335
42. Phillips DM and Bourinbaiar AS (1992) Mechanism of HIV spread from lymphocytes to epithelia. Virology 86: 261-273
43. Phillips DM, Tan X, Perotti ME and Zacharopoulos VR (1998) Mechanism of monocyte-macrophage-mediated transmission of HIV. AIDS Res. Hum. Retroviruses 14 (Suppl. 1): S67-S70
44. McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D and Hope TJ (2003) Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300: 1295-1307
45. Moore JP, McKeating JA, Norton WA and Sattentau QJ (1991) Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4. J. Virol. 65: 1133-1140
46. Jolly C, Kashefi K, Hollinshead M and Sattentau QJ (2004) HIV-1 cell-to-cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199: 283-293
47. Deschambeault J, Lalonde JP, Cervantes-Acosta G, Lodge R, Cohen EA and Lemay G (1999) Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission. J. Virol. 73: 5010-5017
48. Dustin ML and Cooper JA (2000) The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat. Immunol. 1: 23-29
49. Bubb MR, Senderowicz AM, Sausville EA, Duncan KL and Korn ED (1994) Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitivity inhibits the binding of phalloidin of F-actin. J. Biol. Chem. 269: 14869-14871
50. Mitchison T and Cram L (1996) Actin-based cell motility and cell locomotion. Cell 84: 371-379
51. Nakanishi S, Catt KJ and Balla T (1994) Inhibition of agonist-stimulated inositol 1,4,5-trisphosphate production and calcium signaling by the myosin light chain kinase inhibitor, wortmannin. J. Biol. Chem. 269: 6528-6535
52. Davis DM, Igakura T, McCann FE, Carlin LM, Andersson K, Vanherberghen B, Sjostrom A, Bangham CR and Hoglund P (2003) The protean immune cell synapse: a supramolecular structure with many functions. Semin. Immunol. 15: 317-324
53. Blanco J, Bosch B, Fernandez-Figueras MT, Barretina J, Clotet B and Este JA (2004) High level of coreceptor-independent HIV transfer induced by contacts between primary CD4T cells. J. Biol. Chem. 279: 51305-51314
54. Castedo M and Kroemer G (2002) The beauty of death. Trends Cell Biol. 12: 446-447
55. Schwarze SR and Dowdy SF (2000) In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21: 45-48
56. Tabib A, Leroux C, Mornex JF and Loire R (2000) Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-viruspositive patients. Coron. Artery Dis. 11: 41-46
57. McNutt NS, Fletcher V and Conant MA (1983) Early lesions of Kaposi’s sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am. J. Pathol. 111: 62-77
58. Albini A, Barillari G, Benelli R, Gallo RC and Ensoli B (1995) Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA 92: 4838-4842
59. Mitola S, Soldi R, Zanon I, Barra L, Gutierrez MI, Berkhout B, Giacca M and Bussolino F (2000) Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. J. Virol. 74: 344-353
60. Gu Y, Wu RF, Xu YC, Flores SC and Terada LS (2001) HIV Tat activates c- Jun amino-terminal kinase through an oxidant-dependent mechanism. Virology 286: 62-71
61. Biancone L, Cantaluppi V, Boccellino M, Bussolati B, Del Sorbo L, Conaldi PG, Albini A, Toniolo A and Camussi G (1999) Motility induced by human immunodeficiency virus-1 Tat on Kaposi’s sarcoma cells requires plateletactivating factor synthesis. Am. J. Pathol. 155: 1731-1739
62. Wu RF, Gu Y, Xu YC, Mitola S, Bussolino F and Terada LS (2004) Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. J. Virol. 200478: 779-789
63. Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E and Fox HS (2004) Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J. Neuroimmunol. 157: 163-175
64. Chen D, Wang M, Zhou S and Zhou Q (2002) HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J. 21: 6801-6810
65. Campbell GR, Pasquier E, Watkins J, Bourgarel-Rey V, Peyrot V, Esquieu D, Barbier P, de Mareuil J, Braguer D, Kaleebu P, Yirrell DL and Loret EP (2004) The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J. Biol. Chem. 279: 48197-48204
66. Honer B, Shoeman RL and Traub P (1991) Human immunodeficiency virus type 1 protease microinjected into cultured human skin fibroblasts cleaves vimentin and affects cytoskeletal and nuclear architecture. J. Cell Sci. 100: 799-807
67. Shoeman RL, Honer B, Stoller TJ, Kesselmeier C, Miedel MC, Traub P and Graves MC (1990) Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Proc. Natl. Acad. Sci. USA 87: 6336-6340
68. Malorni W, Guiducci G, Pasquinelli G, Rivabene R, Re MC, Ramazzotti E, De Luca M, La Placa M and Cenacchi G (1997) HIV-type 1 induces specific cytoskeleton alterations in human epithelial cells in culture. Eur. J. Dermatol. 7: 263-269
69. Serrador JM, Alonso-Lebrero JL, Del Pozo MA, Furthmayr H, Schwartz-Albiet R, Calvo J, Lozano F and Sanchez-Madrid F (1997) Moesin interacts with the cytoplasmic region of intracellular adhesion molecule-3 and it is redistributed to the uropod of T lymphocytes during cell polarization. J. Cell Biol. 138: 1409-1423
70. Fais S and Malorni W (2003) Leukocytes uropod formation and membrane/ cytoskeleton linkage in immune interactions. J. Leuk. Biol. 73: 556-563
71. Berryman M, Gary R and Bretscher A (1995) Ezrin oligomers are major cytoskeletal components of placental microvilli: a proposal for their involvement in cortical morphogenesis. J. Cell Biol. 131: 1231-1242
72. Fais S, Luciani F, Logozzi M, Parlato S and Lozupone F (2000) Linkage between cell membrane proteins and actin-based cytoskeleton: the cytoskeletal-driven cellular functions. Histol. Histopathol. 15: 539-549
73. Tsukita S, Yonemura S and Tsukita S (1997) ERM proteins: head-to-tail regulation of actin-plasma membrane interaction. Trend Biochem. Sci. 22: 53-58
74. Gautreau A, Louvard D and Arpin M (2000) Morphogenic effects of ezrin require a phosphorilation-induced transition from oligomers to monomers at the plasma membrane J. Cell. Biol. 150: 193-203
75. Klas C, Debatin KM, Jonker RR and Krammer PH (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 6: 625-630
76. Fais S (2002) Importance of the state of activation and/or differentiation of CD4+ T cells in AIDS pathogenesis. Trends Immunol. 23: 128-129
77. Ameisen JC and Capron A (1991) Cell dysfunction and depletion in Aids: the programmed cell death hypothesis. Immunol. Today 12: 102-105
78. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA and Herzenberg LA (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036
79. Estaquier J, Idziorek T, Zou W, Emile D, Faber CM, Bourez JM and Ameisen JC (1995) T helper type 1/T helper type 2 cytokines and T cell death: preventive effects of interleukin 12 on activation-induced and CD95 (Fas/ APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182: 1759-1767
80. Lynch HD, Ramdell F and Anderson MR (1995) Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16: 569-574
81. Giordano S Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R and Galluzzo A (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis. Science 275: 960-963
82. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
83. Peter ME and Krammer PH (1998) Mechanisms of CD95 (APO-1/Fas)- mediated apoptosis. Curr. Opin. Immunol. 10: 545-551
84. Yang Y and Ashwell JD (2001) Exploiting the apoptotic process for management of HIV: are we there yet? Apoptosis 6: 139-146
85. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM and Kupfer A (1995) Apoptosis occur predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1: 129-134
86. Parlato S, Giammarioli A, Logozzi M, Lozupone F, Matarrese P, Luciani F, Falchi M, Malorni W and Fais S (2000) CD95 (APO1/Fas) linkage to the actin cytoskeleton through ezrin in human T-lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19: 5123-5134
87. Lozupone F, Lugini L, Matarrese P, Luciani F, Federici C, Iessi E, Margutti P, Stassi G, Malorni W and Fais S (2004) Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. J. Biol. Chem. 279: 9199-9207
88. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK and Pete ME (2002) Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22: 207-220
89. Thuillier L, Hivroz C, Fagard R, Andeoli C and Mangeat P (1994) Ligation of CD4 surface antigen induces rapid tyrosine phosphorylation in the cytoskeletal protein ezrin. Cell Immunol. 156: 322-331
90. Autero M, Heiska L, Ronnstrand L, Vaheri A, Gahmberg CG and Carpen O (2003) Ezrin is a substrate for Lck in T cells. FEBS Lett. 535: 82-86
91. Liu M, Zeng J and Robey FA (1999) Tyrosine phosphorilation induced by CD4 peptide constructs from HIV Gp120. Peptides 20: 185-191
92. Luciani F, Matarrese P, Giammarioli AM, Lugini L, Lozupone F, Federici C, Iessi E, Malorni W and Fais S (2004) CD95/phosphorilated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95(APO-1/Fas)- mediated apoptosis of human resting CD4+ T lymphocytes. Cell Death Differ. 11: 574-582
93. Siciliano RF (1996) The role of CD4 in HIV envelope-mediated pathogenesis. Curr. Top. Microbiol. Immunol. 205: 159-179
94. Hakomori S (2000) Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj. J. 17: 43-51
95. Kiguchi K, Henning-Chubb CB and Huberman E (1990) Glycosphingolipid patterns of peripheral blood lymphocytes, monocytes, and granulocytes are cell specific. J. Biochem. 107: 8-14
96. Merrit WD, Taylor BJ, Der Minassian V and Reaman GH (1996) Coexpression of GD3 ganglioside with CD45RO in resting and activated human T lymphocytes. Cell Immunol. 173: 131-148
97. Giammarioli AM, Garofalo T, Sorice M, Misasi R, Gambardella L, Gradini R, Fais S, Pavan A and Malorni W (2001) GD3 glycosphingolipid contributes to Fas-mediated apoptosis via association with ezrin cytoskeletal protein. FEBS Lett. 506: 45-50
98. Misasi R, Sorice M, Garofalo T, Griggi T, Giammarioli AM, D’Ettorre G, Vullo V, Pontieri GM, MalorniWand Pavan A (2000) Overexpression of lymphocytic GD3 ganglioside and presence of anti-GD3 antibodies in patients with HIV infection. AIDS Res. Hum. Retroviruses 16: 1539-1549
99. Das V, Nal B, Roumier A, Meas-Yedid V, Zimmer C, Olivo-Marin JC, Roux P, Ferrier P, Dautry-Varsat A and Alcover A (2002) Membrane-cytoskeleton interactions during the formation of the immunological synapse and subsequent T-cell activation. Immunol. Rev. 189: 123-135
100. Conti L, Rainaldi G, Matarrese P, Varano B, Rivabene R, Columba S, Sato A, Belardelli F and Gessani S (1998) The HIV-1 protein acts as a negative regulator of apoptosis in a human lymphoblastoid cell line: possible implications for the pathogenesis of AIDS. J. Exp. Med. 187: 403-413
101. Checroune F, Yao XJ, Gottlinger HG, Bergeron D and Cohen EA (1995) Incorporation of vpr into human immunodeficiency virus type 1: role of conserved regions within the p6 domain of Pr55gag. J. Acquired Immune Defic. Syndr. 10: 1-7
102. Jenkins Y, McEntee M, Weis K and Greene WC (1998) Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J. Cell Biol. 143: 875-885
103. Zhao Y, Yu M, Chen M, Elder RT, Yamamoto A and Cao J (1998) Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virology 246: 266-276
104. Bartz SR, Rogel ME and Emerman M (1996) Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70: 2324-2331
105. Re F, Braaten D, Franke EK and Luban J (1996) Human immunodeficiency virus type 1 cell cycle control: vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70: 2324-2331
106. Ayyavoo V, Mahboubi A, Mahalingam S, Ramalingam R, Kudchodkar S, Williams WV, Green DR and Weiner DB (1997) HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 3: 1117-1123
107. Fukumori T, Akari H, Iida S, Hata S, Kagawa S, Aida Y, Koyama AH and Adachi A (1998) The HIV-1 Vpr displays strong anti-apoptotic activity. FEBS Lett. 432: 17-20
108. Johnson DC and Huber MT (2002) Directed egress of animal viruses promotes cell-to-cell spread. J. Virol. 76: 1-8
109. Matarrese P, Conti L, Varano B, Gauzzi MC, Belardelli F, Gessani S and Malorni W (2000) The HIV-1 vpr protein induces anoikis-resistance by modulating cell adhesion process and microfilament system assembly. Cell Death Differ. 7: 25-36